Our data suggest that EDEM3 acts as a pro-survival factor in prostate cancer cells, and that upregulation of EDEM3 may protect cancer cells from ER stress and have implications for radio-resistance in prostate cancer cell lines. Here, EDEM3 is linked to prostate carcinoma.